Peptides ArchiveAll Peptide Resources in One Archive
Research Use OnlyScientific, regulatory and product-reference information only. No medical advice or human-use recommendation.Compliance Hub

Peptide Laboratory Practice

HPLC Purity vs Peptide Content: Read a COA Correctly

Learn why 99% HPLC purity does not mean 99% peptide content, and how water, counterions, salts, carriers, and calibration alter the true amount in an RUO lot.

Peptide COA archive searchResearch Use OnlyCOA and Quality Control

A peptide can be 99% pure by HPLC and contain only 72% peptide by mass. There is no contradiction. The two numbers answer different questions, yet supplier quotations routinely place “Purity ≥99%” beside a milligram claim as if one verifies the other. For procurement, formulation, and reference preparation, that shortcut creates systematic concentration errors.

HPLC area purity is the main peptide peak area divided by the total integrated area of detected peaks under a stated method. It is a relative chromatographic result. Water, trifluoroacetate, acetate, inorganic salts, many excipients, and non-UV-absorbing carriers may contribute substantial mass while producing little or no signal at the selected wavelength. Material containing a clean peptide plus 20% water can still return 99 area percent.

Peptide content is the amount of target peptide in the weighed material. It requires a calibrated quantitative approach or a justified mass-balance calculation. Amino-acid analysis is often used, while quantitative HPLC against a qualified reference, nitrogen-based approaches, or other compound-appropriate assays may contribute. Each has limitations. A reference standard with an assigned value is not the same as an arbitrary vial labeled “standard.”

Where the missing mass goes

Synthetic peptides commonly arrive as TFA or acetate salts. Basic residues can bind multiple counterion equivalents, and the exact amount varies with purification and salt-exchange history. Hygroscopic material absorbs water during handling. Residual organic solvents, inorganic salts, and process-related material add further mass. Lyophilization removes bulk solvent but does not guarantee a dry, counterion-free peptide.

Cosmetic peptide premixes present an even larger trap. The active may be diluted into water, glycerin, dextran, maltodextrin, or preservative systems. A 5% active blend made from highly pure peptide can legitimately show a clean peptide peak. Calling the whole powder or liquid “99% peptide” would still be false.

A useful mass balance lists target peptide, water, counterions, residual solvents, inorganic residue, declared carrier, and identified organic impurities. The total will not always close perfectly because methods carry uncertainty, but a 15–25% unexplained gap should trigger investigation. Do not “correct” it by assuming every unmeasured gram is peptide.

Why a clean chromatogram can be misleading

Integration settings matter. A supplier can exclude early solvent-front peaks, late hydrophobic material, or peaks below an arbitrary threshold. Short deletion sequences may have weak retention. Compounds without aromatic residues can give low UV response at 280 nm. Different impurities do not necessarily share the parent peptide’s extinction coefficient, so area percent is not automatically mass percent even among UV-visible components.

Ask for the uncropped chromatogram, acquisition wavelength, column, gradient, injection concentration, integration report, and blank. Review the baseline before and after the main peak. A single chromatogram without system suitability or reference comparison is a picture, not a release method.

Identity remains separate. A 99% peak can be the wrong peptide. Intact LC-MS supports molecular mass, while peptide mapping or MS/MS may be needed for sequence and modification assignment. Isomeric or stereochemical errors can share the same mass. The quality package should therefore answer identity, related substances, assay, and physical mass contributors as distinct release questions.

A practical calculation

Suppose a vial is labeled 10 mg. Quantitative testing finds 8.0 mg target peptide. Karl Fischer water is 8%, counterion is 9%, and residual solvents plus related peptides account for the remainder within method uncertainty. The HPLC purity of the organic peptide-related fraction may still be 99%. Preparing a stock as though all 10 mg were active peptide creates a 20% concentration error.

The correction factor is based on assigned peptide content, not HPLC area purity. Laboratories should also decide whether their reported concentration is peptide free base, salt, or as-is material. That basis belongs in the notebook and certificate. Otherwise two teams can weigh the same lot correctly and report different molar concentrations.

COA checklist for purchasing

FDA and ICH specification principles separate assay from impurity testing for a reason. Regulatory guidance for highly purified synthetic peptides also emphasizes sensitive, high-resolution characterization of peptide-related impurities. An RUO supplier is not filing a drug application, but those analytical distinctions remain sound laboratory practice.

Reject a certificate that uses “assay,” “purity,” and “peptide content” interchangeably. Ask the supplier to explain the denominator and method for every percentage. Peptides Archive can help a research procurement team map COA fields to the intended calculation before a lot is accepted. This page provides RUO quality guidance only, not compounding, dosing, or human-use instruction.

Quantitative uncertainty also belongs on the review sheet. Amino-acid recovery varies by residue and hydrolysis condition; calibrated HPLC depends on the assigned value of the standard; water and counterion tests each carry sampling error. A result of 80.0% should not be treated as exact to one decimal place simply because software prints it that way. Trend replicate preparations and include an uncertainty or method-precision statement appropriate to the decision. If a tight customer specification cannot be distinguished from method noise, improve the method before negotiating the limit.

For routine stocks, keep the original content calculation with the balance printout, lot certificate, and preparation worksheet. When a lot changes, do not carry forward the old correction factor merely because the catalog name is unchanged. Recalculate from the new batch’s assigned content.

Primary records and verification routes

Use the primary paper, current regulator record, or lot-linked analytical file for the claim it supports. A search result is a route to evidence, not evidence itself.

Research Use Only. No dosing, administration, compounding, or human-use guidance is provided.